Discovered a switch that regulates inflammation, a study published in Nature
on April 2, 2012 The cells of the immune system possess powerful weapons that are able to fight off the invasion of microorganisms, yet at the same time can cause collateral damage. In particular, the Th17 lymphocytes, which carry this name because they produce interleukin-17, are important for the protection against fungi and bacteria but […]
Mechanism of migration of the inflammatory cells published in the Journal of Experimental Medicine
on March 22, 2012 During tissue damage, the protein of the alarmin family, HMGB1, released from the cells, was shown to be capable of attracting cells from the peripheral blood and to start the inflammatory process which can be either positive i.e., repair the damage or negative i.e., continue in a chronic inflammation. The mechanism […]
Prof. Renato Dulbecco, Nobel Prize of Physiology or Medicine 1975, former Member of the IRB Scientific Advisory Board passed away
on February 20, 2012 It is with profound regrets that the IRB got to know that Prof. Renato Dulbecco passed away. Besides being a famous scientist, Prof. Dulbecco was a former Member of the IRB Scientific Advisory Board. Prof. Dulbecco together with Prof. Temin and Prof. Baltimore was awarded with the Nobel Prize for Medicine […]
EU invests in a research with Brazil to fight inflammatory disorders, the IRB is one of the grantees
on January 23, 2012 Takes place today in Bruxelles the kick-off meeting of the collaborative research programme – Targeting novel mechanisms of resolution in inflammation (TIMER) – which will accelerate the development of novel and powerful strategies to fight inflammation. TIMER is co-funded with €3M by the European Commission to establish robust collaboration with Brazil […]
Francesca Ronchi Awarded PhD
on November 14, 2011 Francesca Ronchi successfully defended her PhD thesis, which was presented at the University Vita Salute San Raffaele, Milano, Italy. Her work entitled “On the role of IL-1-beta in T cell-mediated immunopathology” was performed in the laboratory of Federica Sallusto. Francesca’s supervisor at the University Vita Salute San Raffaele was Vincenzo Barnaba. […]
EADV meeting: Chronic inflammatory and autoimmune diseases: practical issues and fundamental advances
on November 11, 2011 11 November 2011 – IRB, Bellinzona / 17 November 2011 – Regional Hospital, Lugano For the third time, the clinical and scientific meeting of the European Academy of Dermatology and Venereology (EADV) is taking place in Ticino. The meeting is divided into two sessions: a research (November 11, 2011, at the […]
The new PhD Program is online
on October 27, 2011 The International PhD program in Immunology, Cell Biology and Biochemistry for 2011-2012 is published. It will initiate on November 10, 2011 with a conference from Jos A.G. Van Strijp, “Strategies in pathogenesis research”.
Federica Sallusto elected EMBO Member
on October 21, 2011 The European Molecular Biology Organization (EMBO) promotes excellence in molecular life sciences in Europe by recognizing scientists renowned for their outstanding contributions to research covering classical areas of molecular biology as well as other fields such as systems biology, neuroscience and cancer biology. Since 1964, leading scientists are elected annually to […]
The 2011 Nobel Prize in Physiology or Medicine goes to Prof. Ralph Steinman, a former member of the IRB Scientific Advisory Board
on October 4, 2011 Yesterday morning the IRB was delighted to learn that the Nobel Assembly had decided to honour Bruce Beutler (The Scripps Research Institute, La Jolla), Jules Hoffmann (University of Strasbourg), and Ralph Steinman (The Rockefeller University, New York) with the 2011 Nobel Prize in Physiology or Medicine. This news, however, was soon […]
EU invests €30 million to boost vaccine research, the IRB is one of the 42 grantees
on September 29, 2011 On 1 October 2011 the collaborative research programme – Advanced Immunization Technologies (ADITEC) – will start in order to accelerate the development of novel and powerful immunization technologies for the next generation of human vaccines. ADITEC is co-funded with €30M by the European Commission to establish a robust platform for innovation […]
